IL33 and neoplasm: From this perspective, using a cohort of Chilean patients, we analyzed the association of IL-33/ST2 content and distribution with CRC progression and clinical/histopathological features (TNM staging, desmoplasia, tumor localization, among others) in tumor and healthy tissue.